Caprylhydroxamic acid

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Caprylhydroxamic acid
DrugBank Accession Number
DB16634
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 159.229
Monoisotopic: 159.125928791
Chemical Formula
C8H17NO2
Synonyms
  • Caprylohydroxamic acid
  • N-Hydroxyoctanamide
  • Octanohydroxamic acid
  • Octanoylhydroxamic acid
  • Taselin

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Purus antibacterial wipesCaprylhydroxamic acid (0.0168 g/56g) + Ethanol (0.0112 mL/56g) + Glyceryl laurate (0.0448 g/56g) + Laevulinic Acid (0.028 g/56g)ClothTopicalThe fab Korea Co., Ltd.2020-05-04Not applicableUS flag
Purus antibacterial wipesCaprylhydroxamic acid (0.0112 g/56g) + Ethanol (0.0112 mL/56g) + Glyceryl laurate (0.0448 g/56g) + Laevulinic Acid (0.028 g/56g)ClothTopicalThe fab Korea Co., Ltd.2020-09-02Not applicableUS flag
SureWell Sanitizing WipesCaprylhydroxamic acid (4 g/100g) + Ethanol (3 g/100g) + Glyceryl laurate (6 g/100g)LiquidTopicalIfons Corp.2020-08-22Not applicableUS flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
UPY805K99W
CAS number
7377-03-9
InChI Key
RGUVUPQQFXCJFC-UHFFFAOYSA-N
InChI
InChI=1S/C8H17NO2/c1-2-3-4-5-6-7-8(10)9-11/h11H,2-7H2,1H3,(H,9,10)
IUPAC Name
N-hydroxyoctanamide
SMILES
CCCCCCCC(=O)NO

References

General References
Not Available
ChemSpider
22293
RxNav
1307145
ZINC
ZINC000095740180

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
ClothTopical
LiquidTopical
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP1.89Chemaxon
pKa (Strongest Acidic)8.91Chemaxon
pKa (Strongest Basic)-5.5Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count2Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area49.33 Å2Chemaxon
Rotatable Bond Count6Chemaxon
Refractivity43.86 m3·mol-1Chemaxon
Polarizability18.7 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0cfv-9200000000-bc516375c494da8f7ae2
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-056r-0900000000-517eabc900456190c89e
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-9000000000-f34bab37f956815e5d1e
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4i-1900000000-ede5ac2c60d20fda1aec
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4l-9000000000-5f40776740408e00cb19
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-082e8c231f370a1a4cb9
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-143.9111921
predicted
DarkChem Lite v0.1.0
[M-H]-139.49104
predicted
DeepCCS 1.0 (2019)
[M+H]+145.7150921
predicted
DarkChem Lite v0.1.0
[M+H]+142.59804
predicted
DeepCCS 1.0 (2019)
[M+Na]+151.90498
predicted
DeepCCS 1.0 (2019)

Drug created at March 07, 2021 17:49 / Updated at March 08, 2021 03:36